• 華中科技大學(xué)同濟(jì)醫(yī)學(xué)院同濟(jì)醫(yī)院器官移植研究所(武漢430030);

引用本文： 陳實(shí). HLA配型對(duì)肝移植的影響. 中國(guó)普外基礎(chǔ)與臨床雜志, 2007, 14(2): 125-127. doi: 復(fù)制

1. 　Neumann UP, Guckelberger O, Langrehr JM， et al. 　Impact of human leukocyte antigen matching in liver transplantation [J]. Transplantation， 2003； 75(1)∶132.
2. 　Kasahara M, Kiuchi T, Uryuhara K,　et al. Role of HLA compatibility in pediatric livingrelated liver transplantation [J]. Transplantation， 2002； 74(8)∶1175.
3. 　Sieders E, Hepkema BG, Peeters PM，　et al. The effect of HLA mismatches, shared crossreactive antigen groups, and shared HLADR antigens on the outcome after pediatric liver transplantation [J]. Liver Transpl， 2005; 11(12)∶1541.
4. 　Campos J, Quijano Y, Franco A, et al. Beneficial effects of HLA class Ⅱ incompatibility in living donor liver transplantation [J]. Transplant Proc， 2003; 35(5)∶1888.
5. 　Doran TJ, Geczy AF, Painter D, et al. A large, single center investigation of the immunogenetic factors affecting liver transplantation [J]. Transplantation， 2000； 69(7)∶1491.
6. 　Muro M, Marin L, Miras M, et al. Liver recipients harbouring antidonor preformed lymphocytotoxic antibodies exhibit a poor allograft survival at the first year after transplantation: experience of one centre [J]. Transpl Immunol， 2005; 14(2)∶91.
7. 　Matinlauri IH, Hockerstedt KA, Isoniemi HM. Equal overall rejection rate in pretransplant flowcytometric crossmatch negative and positive adult recipients in liver transplantation [J]. Clin Transplant， 2005; 19(5)∶626.
8. 　Donaldson PT, Alexander GJ, O’Grady J, et al. Evidence for an immune response to HLA class Ⅰ antigens in the vanishingbileduct syndrome after liver transplantation [J]. Lancet, 1987; 1（8539）∶945.
9. 　Lobo PI, Spencer C, Douglas MT, et al. The lack of longterm detrimental effects on liver allografts caused by donorspecific antiHLA antibodies [J]. Transplantation, 1993； 55（5）∶1063.
10. 　Karuppan S, Ericzon BG, Moller E. Relevance of a positive crossmatch in liver transplantation [J]. Transpl Int, 1991; 4（1）∶18.
11. 　Katz SM, Kimball PM, Ozaki C, et al. Positive pretransplant crossmatches predict early graft loss in liver allograft recipients [J]. Transplantation, 1994; 57（4）∶616.
12. 　Saidman SL, Duquesnoy RJ, Demetris AJ, et al. Combined liverkidney transplantation and the effect of preformed lymphocytotoxic antibodies [J]. Transpl Immunol, 1994; 2（1）∶ 61.
13. 　Girnita AL, Webber SA， Zeevi A. AntiHLA alloantibodies in pediatric solid organ transplantation [J]. Pediatric Transplant, 2006; 10(2) ∶146.
14. 　Neumann UP, Langrehr JM, Naumann U, et al. Impact of HLAcompatibilities in patients undergoing liver transplantation for HBVcirrhosis [J]. Clin Transplant, 2002; 16(2)∶122.
15. 　Kimball P, Stravitz T. DR antigens influence graft outcome and HCV recurrence after liver transplantation [J]. Transplant Proc, 2005; 37(2)∶1099.
16. 　Manez R, White LT, Linden P, et al. The influence of HLA matching on cytomegalovirus hepatitis and chronic rejection after liver transplantation [J]. Transplantation, 1993; 55(5)∶1067.
17. 　Markus BH, Duquesnoy RJ, Gordon RD, et al. Histocompatibility and liver transplant outcome. Does HLA exert a dualistic effect? [J]. Transplantation, 1988; 46(3)∶372.
  1. 1. 　Neumann UP, Guckelberger O, Langrehr JM， et al. 　Impact of human leukocyte antigen matching in liver transplantation [J]. Transplantation， 2003； 75(1)∶132.
  2. 2. 　Kasahara M, Kiuchi T, Uryuhara K,　et al. Role of HLA compatibility in pediatric livingrelated liver transplantation [J]. Transplantation， 2002； 74(8)∶1175.
  3. 3. 　Sieders E, Hepkema BG, Peeters PM，　et al. The effect of HLA mismatches, shared crossreactive antigen groups, and shared HLADR antigens on the outcome after pediatric liver transplantation [J]. Liver Transpl， 2005; 11(12)∶1541.
  4. 4. 　Campos J, Quijano Y, Franco A, et al. Beneficial effects of HLA class Ⅱ incompatibility in living donor liver transplantation [J]. Transplant Proc， 2003; 35(5)∶1888.
  5. 5. 　Doran TJ, Geczy AF, Painter D, et al. A large, single center investigation of the immunogenetic factors affecting liver transplantation [J]. Transplantation， 2000； 69(7)∶1491.
  6. 6. 　Muro M, Marin L, Miras M, et al. Liver recipients harbouring antidonor preformed lymphocytotoxic antibodies exhibit a poor allograft survival at the first year after transplantation: experience of one centre [J]. Transpl Immunol， 2005; 14(2)∶91.
  7. 7. 　Matinlauri IH, Hockerstedt KA, Isoniemi HM. Equal overall rejection rate in pretransplant flowcytometric crossmatch negative and positive adult recipients in liver transplantation [J]. Clin Transplant， 2005; 19(5)∶626.
  8. 8. 　Donaldson PT, Alexander GJ, O’Grady J, et al. Evidence for an immune response to HLA class Ⅰ antigens in the vanishingbileduct syndrome after liver transplantation [J]. Lancet, 1987; 1（8539）∶945.
  9. 9. 　Lobo PI, Spencer C, Douglas MT, et al. The lack of longterm detrimental effects on liver allografts caused by donorspecific antiHLA antibodies [J]. Transplantation, 1993； 55（5）∶1063.
  10. 10. 　Karuppan S, Ericzon BG, Moller E. Relevance of a positive crossmatch in liver transplantation [J]. Transpl Int, 1991; 4（1）∶18.
  11. 11. 　Katz SM, Kimball PM, Ozaki C, et al. Positive pretransplant crossmatches predict early graft loss in liver allograft recipients [J]. Transplantation, 1994; 57（4）∶616.
  12. 12. 　Saidman SL, Duquesnoy RJ, Demetris AJ, et al. Combined liverkidney transplantation and the effect of preformed lymphocytotoxic antibodies [J]. Transpl Immunol, 1994; 2（1）∶ 61.
  13. 13. 　Girnita AL, Webber SA， Zeevi A. AntiHLA alloantibodies in pediatric solid organ transplantation [J]. Pediatric Transplant, 2006; 10(2) ∶146.
  14. 14. 　Neumann UP, Langrehr JM, Naumann U, et al. Impact of HLAcompatibilities in patients undergoing liver transplantation for HBVcirrhosis [J]. Clin Transplant, 2002; 16(2)∶122.
  15. 15. 　Kimball P, Stravitz T. DR antigens influence graft outcome and HCV recurrence after liver transplantation [J]. Transplant Proc, 2005; 37(2)∶1099.
  16. 16. 　Manez R, White LT, Linden P, et al. The influence of HLA matching on cytomegalovirus hepatitis and chronic rejection after liver transplantation [J]. Transplantation, 1993; 55(5)∶1067.
  17. 17. 　Markus BH, Duquesnoy RJ, Gordon RD, et al. Histocompatibility and liver transplant outcome. Does HLA exert a dualistic effect? [J]. Transplantation, 1988; 46(3)∶372.